Navigation Links
NIH awards Phylonix phase II SBIR to develop zebrafish models for eye diseases
Date:10/2/2007

Cambridge, MA October 2, 2007 Phylonix Pharmaceuticals, Inc. today announced that it has been awarded a $1,092,031 Phase II Small Business Innovation Grant (SBIR) from the National Eye Institute of the National Institutes of Health (NIH) to develop zebrafish eye disease models for drug screening. The grant for New Models for Eye Diseases will support the Phylonix program over a period of three years.

The eye is a highly conserved organ and the basic structure between human and zebrafish eyes is indistinguishable. In addition, numerous eye diseases have been modeled in zebrafish including choroidal neovascularization, similar to age-related macular degeneration (AMD) in humans; ocular scarring that occurs after surgery for glaucoma; retinopathy induced by diabetes and edema; and ocular ischemia caused by several pathologies.

The funding for this program will be used to further develop our novel, patent pending methods for modeling eye diseases and to identify potential drug candidates, commented Patricia McGrath, Phylonix President and Chief Executive Officer. Our preliminary data show good correlation between results in zebrafish and results in mammals and we are very pleased to receive this Phase II SBIR award from the National Eye Institute.

Phylonix is modeling a number of eye diseases in zebrafish including diabetic retinopathy and AMD, the two leading causes of blindness in adults in the industrialized world. Both conditions involve vascular abnormalities, proliferation and leakage of new blood vessels. Other eye diseases resulting in blindness that Phylonix is modeling in zebrafish include retinopathy of prematurity, a major cause of newborn blindness in premature infants maintained by oxygen supplementation during the postnatal period. This disease involves intense neovascularization of the retina and leads to retinal detachment. Another cause of blindness is corneal neovascularization, which often results from injury and infecti
'/>"/>

Contact: Edward O'Lear
ed.olear@phylonix.com
617-441-6700
Phylonix
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Aussie Nobel Prize Winners Receive Their Awards
2. Prestigious Gairdner Awards for medical research in 2006 Goes To Two Yale biologists
3. The President Gives Away National Disability Awards
4. Majority of Padma Awards Go to Doctors from Delhi
5. US, Indian Doctors Bag Thai Medical Awards
6. WHO Awards Prequalification Status to the First UAE Approved Vaccine
7. Bio-Rad Gets Life Science Industry Awards – 200
8. Michael J. Fox Foundation Awards $710,000 to Understanding of Parkinsons Disease Subtypes
9. Ontario Court Awards Compensation To Paralyzed Worker
10. Talwalkars Awards a Record $1 Million Order to Nautilus
11. NIH Awards Emory $3.6 Million for Schizophrenia Gene Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Baltimore, MD (PRWEB) , ... July 29, 2015 , ... ... to Get Checked for Skin Cancer ," discussed the importance of having regular skin ... if a person has excessive exposure to ultraviolet rays. When caught early, skin cancer ...
(Date:7/29/2015)... ... July 29, 2015 , ... Several years ago, in order ... with autism, Little City took a proactive stance and began planning the Children’s Village ... grant provides valuable support to building the third home. , “We are very pleased ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... Since the late 1970s, Dr. Cottrell has been making predictions about the economy, ... Earth, documents many of these prognostications. He warns that extreme weather conditions and ...
(Date:7/29/2015)... North Carolina (PRWEB) , ... July 29, 2015 ... ... MetLife, Inc ., a global provider of life insurance, annuities, employee benefits ... Team Challenge North Carolina inclusive sporting event taking place in Charlotte, North ...
(Date:7/29/2015)... , ... July 29, 2015 , ... ... is seeking funding for a study on the potentially lifesaving impact of removing ... today . , The research proposal is based on a successful pilot ...
Breaking Medicine News(10 mins):Health News:Get Checked for Skin Cancer Early and Often 2Health News:Get Checked for Skin Cancer Early and Often 3Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3
... good for heart health, at least among men, a ... researcher Robert Gramling, M.D., D.Sc., found that men who ... actually experienced a three times lower incidence of death ... not support the same conclusion among women. One possible ...
... Australian first, scientists at Sydney,s Centenary Institute have mapped ... has the potential to turn the way we discover ... time for new treatments. , "These membrane proteins are ... an increased,understanding of them is vital for future drug ...
... Theoretical Bioinformatics at the German Cancer Research Center (Deutsches ... how cells decide whether or not to migrate. Using ... molecular targets within a cell that have to be ... direction. This method may help to develop new treatments ...
... YORK and PARSIPPANY, N.J., July 14 Healthfirst ... a free online service,for electronic claims submissions. This ... medical providers to do business with the health ... faster exchange of,information, higher acceptance rates and quicker ...
... announced the appointment of Gregory Ciottone,MD to the position of Chief ... ... Company., LONGMONT, Colo., July 14 ... Ciottone, MD,to the position of Chief Medical Officer. Dr. Ciottone will ...
... Combat Lifesaver ... ... the summer of 2005, the,U.S. Army approached Recon Mountaineer(R) LLC ... the Combat Lifesaver program, and,at gaining their approval, the TC3(R) ...
Cached Medicine News:Health News:Positive thinking is prescription for the heart 2Health News:Discovery first step to new therapies 2Health News:Cellular decision on the computer 2Health News:Healthfirst and MD On-Line Partner to Streamline Claims Processing 2Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 2Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 3Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 4Health News:American Hospital Management Company Appoints Gregory Ciottone, MD as Chief Medical Officer 5Health News:Creator of Recon Moutaineer's Tactical Combat Casualty Care Bag Praises Combat Lifesavers 2
(Date:7/29/2015)... -- RXi Pharmaceuticals Corporation (NASDAQ: RXII ), a biotechnology ... in the areas of dermatology and ophthalmology today announced ... quarter ended June 30, 2015 on Wednesday, August 12, ... A live audio webcast will begin ... under the "Investors" section of the Company,s website, ...
(Date:7/29/2015)... July 29, 2015   BioLife Solutions , Inc. ... marketer of proprietary clinical grade hypothermic storage ... thermal shipping products for cells and tissues  ("BioLife" ... quarter 2015 financial results will be released on Thursday, ... a conference call and live webcast at 1:30 p.m. ...
(Date:7/29/2015)... Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today that ... District of West Virginia (W.Va) pushed ... to start in November. The first trial that was set ... and now it involves 39 women, and the trial has ... an article in Reuters. The alterations were made after data ...
Breaking Medicine Technology:RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 2RXi Pharmaceuticals to Webcast Second Quarter 2015 Financial Results on Wednesday, August 12, 2015 3BioLife Solutions to Report Second Quarter 2015 Financial Results and Provide Business Update on August 6, 2015 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... 28 BioCis Pharma Ltd., a,privately-held drug development ... Phase I clinical testing of ProtoCure(TM) intravesical,instillation solution, ... is based on a new mechanism of action ... cancer growth and proliferation,locally. , ...
... a leader in the field of human gene therapy,announced ... Drug,Designation to AMT,s gene therapy product AMT-021 for the ... Orphan Drug Designation for AIP entitles AMT to ... AMT-021 if this,product candidate is the first new drug ...
Cached Medicine Technology:BioCis Pharma Starts a Phase I Clinical Trial With a New Cancer Drug 2AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria 2AMT Receives EMEA Orphan Drug Designation for Acute Intermittent Porphyria 3
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 9.0 mm and length 6 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 8 mm....
Extremely wide blade opening. Excellent bio and MRI compatibility. Lot number on each clip. Long reliable history. Standard type 1/1 (mm), opening width 8.0 mm and length 7 mm....
... Signature is a state of the ... integrates blood, sterile body fluid and ... microbiology workstation with comprehensive capabilities. It ... and where expanded flexibility in operating ...
Medicine Products: